Protocols

Multi-peptide protocols and patient journeys that outline how individual compounds are used together in clinical and research contexts. Each protocol includes rationale, dosing tables, cycle structure, monitoring guidance, and comprehensive safety information with citations to primary literature.

Important Notice

These protocols are educational syntheses of published research. They do not constitute prescribing guidance. Multi-peptide combinations may not have been studied in clinical trials and should only be used under direct medical supervision.

Tissue Repair Research Only

Injury Recovery

BPC-157 + TB-500

A protocol combining BPC-157 for local tissue repair with TB-500 for systemic healing support. Covers loading and maintenance phases, contraindications, monitoring, and the evidence basis for combination use.

Subcutaneous 4-6 Week Cycle
GLP-1 Agonist FDA Approved

GLP-1 Patient Journey

Semaglutide & Tirzepatide

A comprehensive guide to starting and maintaining GLP-1 receptor agonist therapy. Covers pre-treatment screening, titration, GI side effect management, monitoring, maintenance, discontinuation considerations, and lifestyle integration.

Subcutaneous Long-Term Therapy
GH Axis Research Only

GH Secretagogue Stack

CJC-1295 + Ipamorelin

A synergistic GHRH + GHRP protocol for optimizing pulsatile growth hormone release. Covers timing, cycle structure, IGF-1 monitoring, and glucose management.

Subcutaneous 12-Week Cycle
Longevity Research Only

Anti-Aging & Longevity

Epithalon + GHK-Cu + MOTS-c

A multi-target longevity protocol combining telomerase activation, tissue remodeling, and mitochondrial optimization. Covers staggered cycling and monitoring strategies.

Subcutaneous Cycled
Neuropeptides Research Only

Cognitive Enhancement

Semax + Selank

A nootropic neuropeptide stack combining stimulating cognitive enhancement (Semax) with anxiolytic support (Selank). Intranasal administration with rapid onset.

Intranasal 2-4 Week Cycle
Immune Research Only

Immune Support

Thymosin Alpha-1 + LL-37

An immune optimization protocol combining adaptive immunity enhancement (TA1) with innate antimicrobial defense (LL-37). Covers use cases, CBC monitoring, and immunoglobulin tracking.

Subcutaneous 4-12 Week Cycle
Body Composition Research Only

Body Composition

Tesamorelin + AOD-9604

A fat loss and recomposition protocol combining FDA-approved GHRH analog (Tesamorelin) with the lipolytic HGH fragment (AOD-9604). Covers DEXA monitoring and lifestyle integration.

Subcutaneous 12-Week Cycle